Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.47 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.44 |
| ▸ | S1PR4 | O95977 | 5/20 | 0.44 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.44 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.44 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | KDM5A | P29375 | 2/20 | 0.40 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.40 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.40 |
| ▸ | NAAA | Q02083 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.39 |
| ▸ | ADH1B | P00325 | 1/20 | 0.39 |
| ▸ | ADH1C | P00326 | 1/20 | 0.39 |
| ▸ | ADH1A | P07327 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10988487 | 0.98 | ALDH1A1 (0.54) | ALDH1A1TSHRPAOXS1PR2S1PR4 | |
| SCHEMBL25506915 | 0.96 | TSHR (0.48) | ALDH1A1TSHRPAOXS1PR2S1PR4 | |
| SCHEMBL6722890 | 0.92 | ALDH1A1 (0.62) | ALDH1A1TSHRPAOXS1PR2S1PR4 | |
| SCHEMBL5703952 | 0.92 | ALDH1A1 (0.62) | ALDH1A1TSHRPAOXS1PR2S1PR4 | |
| SCHEMBL11799766 | 0.92 | ALDH1A1 (0.62) | ALDH1A1TSHRPAOXS1PR2S1PR4 | |
| SCHEMBL20561984 | 0.90 | ALDH1A1 (0.50) | ALDH1A1TSHRPAOXS1PR2S1PR4 | |
| SCHEMBL29286822 | 0.90 | ALDH1A1 (0.48) | ALDH1A1TSHRPAOXS1PR2S1PR4 | |
| SCHEMBL29286841 | 0.90 | ALDH1A1 (0.48) | ALDH1A1TSHRPAOXS1PR2S1PR4 | |
| SCHEMBL10988578 | 0.90 | ALDH1A1 (0.48) | ALDH1A1TSHRPAOXS1PR2S1PR4 | |
| SCHEMBL626029 | 0.89 | TSHR (0.65) | ALDH1A1TSHRPAOXS1PR2S1PR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3281619-B1 | SHAMPOO CONTAINING A GEL NETWORK | PROCTER & GAMBLE (US) | 2021-01-20 | — | — | EP | disclosed |
| US-10130567-B2 | Oral compositions containing gel networks | THE PROCTER & GAMBLE COMPANY (US) | 2018-11-20 | — | — | US | disclosed |
| US-20180133118-A1 | Oral Compositions Containing Gel Networks | PROCTER & GAMBLE (US) | 2018-05-17 | — | — | US | disclosed |
| EP-3281619-A1 | SHAMPOO CONTAINING A GEL NETWORK | The Procter & Gamble Company (US) | 2018-02-14 | — | — | EP | disclosed |
| EP-3013309-B1 | A STAIN-PROOF ORAL CARE COMPOSITION | PROCTER & GAMBLE (US) | 2017-12-27 | — | — | EP | disclosed |
| EP-2068816-B1 | ORAL COMPOSITIONS CONTAINING GEL NETWORKS | PROCTER & GAMBLE (US) | 2017-11-08 | — | — | EP | disclosed |
| US-20170216158-A1 | Oral Compositions Containing Gel Networks | PROCTER & GAMBLE (US) | 2017-08-03 | — | — | US | disclosed |
| US-9655819-B2 | Oral compositions containing gel networks | THE PROCTER & GAMBLE COMPANY (US) | 2017-05-23 | — | — | US | disclosed |
| EP-3127583-A1 | A METHOD OF DEMONSTRATING STAIN-PROOF EFFICACY OF AN ORAL CARE COMPOSITION | The Procter and Gamble Company (US) | 2017-02-08 | — | — | EP | disclosed |
| US-20160287489-A1 | Oral Compositions Containing Gel Networks | PROCTER & GAMBLE (US) | 2016-10-06 | — | — | US | disclosed |
| US-8361449-B2 | Detersive surfactant, a fatty alcohol in a solid crystalline gel phase dispersed in the shampoo; aqueous carrier; conditioner | THE PROCTER & GAMBLE COMPANY (US) | 2013-01-29 | — | — | US | disclosed |
| US-8349301-B2 | Mixture of surfactants, fatty amphiphiles and aqueous carrier | THE PROCTER & GAMBLE COMPANY (US) | 2013-01-08 | — | — | US | disclosed |
| US-20110089073-A1 | Methods And Compositions For Hydrophobic Modification Of Oral Cavity Surfaces | THE PROCTER & GAMBLE COMPANY (US) | 2011-04-21 | — | — | US | disclosed |
| EP-2068816-A2 | ORAL COMPOSITIONS CONTAINING GEL NETWORKS | The Procter and Gamble Company (US) | 2009-06-17 | — | — | EP | disclosed |
| EP-1924237-A1 | SHAMPOO CONTAINING A GEL NETWORK | The Procter and Gamble Company (US) | 2008-05-28 | — | — | EP | disclosed |
| WO-2008042279-A2 | ORAL COMPOSITIONS CONTAINING GEL NETWORKS | THE PROCTER & GAMBLE COMPANY (US) | 2008-04-10 | — | — | WO | disclosed |
| US-20080081023-A1 | for desired rheology; comprising: i) fatty amphiphiles; ii) secondary surfactants; and iii) solvents; and b) an oral carrier phase; toothpaste, dentifrice, tooth gel; mouth rinse | PROCTER & GAMBLE COMPANY, THE | 2008-04-03 | — | — | US | disclosed |
| US-20070110700-A1 | Shampoo containing a gel network | PROCTER & GAMBLE COMPANY, THE | 2007-05-17 | — | — | US | disclosed |
| WO-2007040571-A1 | SHAMPOO CONTAINING A GEL NETWORK | THE PROCTER & GAMBLE COMPANY (US) | 2007-04-12 | — | — | WO | disclosed |
| US-20060024256-A1 | Mixture of surfactants, fatty amphiphiles and aqueous carrier | PROCTER & GAMBLE COMPANY, THE | 2006-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060024256-A1 | Mixture of surfactants, fatty amphiphiles and aqueous carrier | FABP4, SGMS2, SGMS1 | ALDH1A1 4425/4885TSHR 4246/4885PAOX 4/4885 |
| US-20110089073-A1 | Methods And Compositions For Hydrophobic Modification Of Oral Cavity Surfaces | PTMS, TAS2R39, CASP3 | ALDH1A1 4358/4885TSHR 1071/4885PAOX 3395/4885 |
| US-20160287489-A1 | Oral Compositions Containing Gel Networks | FABP2, FASN, COG7 | ALDH1A1 2954/4885TSHR 4851/4885PAOX 469/4885 |
| US-20180133118-A1 | Oral Compositions Containing Gel Networks | FABP2, FASN, COG7 | ALDH1A1 2954/4885TSHR 4851/4885PAOX 469/4885 |
| US-20080081023-A1 | for desired rheology; comprising: i) fatty amphiphiles; ii) secondary surfactants; and iii) solvents; and b) an oral carrier phase; toothpaste, dentifrice, tooth gel; mouth rinse | TAS2R30, TAS2R43, TAS2R31 | ALDH1A1 3231/4885TSHR 4358/4885PAOX 716/4885 |
| US-20170216158-A1 | Oral Compositions Containing Gel Networks | FABP2, FASN, COG7 | ALDH1A1 2954/4885TSHR 4851/4885PAOX 469/4885 |
| US-20070110700-A1 | Shampoo containing a gel network | POLR1C, POLQ, POLN | ALDH1A1 4118/4885TSHR 4482/4885PAOX 8/4885 |
| US-10130567-B2 | Oral compositions containing gel networks | FABP2, FASN, COG7 | ALDH1A1 2954/4885TSHR 4851/4885PAOX 469/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.